Standards, Options and Recommendations (SOR) for diagnosis, treatment and follow-up of osteosarcoma;Standards, Options et Recommandations (SOR) pour le diagnostic, le traitement et la surveillance de l'osteosarcome

Bulletin du Cancer

Volumn 86, Issue 2, 1999, Pages 159-176

  Philip, Thierry ^a   Blay, Jean Yves ^a   Brunat Mentigny, Maud ^a   Carrie, Christian ^a   Chauvot, Paul ^a   Farsi, Fadila ^a   Fervers, Béatrice ^a   Gentet, Jean Claude ^b   Giammarile, Francesco ^a   Kohler, Rémi ^c   Mathoulin, Simone ^d   Patricot, Louis Marc ^e   Thiesse, Philippe ^a  

^a CENTRE LÉON BÉRARD   (France)

^b TIMONE HOSPITAL   (France)

^c EDOUARD HERRIOT HOSPITAL   (France)

^d Centre national d'hemovigilance   (France)

^e CROIX ROUSSE HOSPITAL   (France)

Author keywords

Adult; Cancer; Chemotherapy; Guidelines; Neoplasms; Osteosarcoma; Pediatric; Sarcoma of the bone; Surgery

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; DOXORUBICIN; IFOSFAMIDE; METHOTREXATE;

AMPUTATION; ARTICLE; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL TRIAL; DIAGNOSTIC IMAGING; DRUG MEGADOSE; FOLLOW UP; HUMAN; OSTEOSARCOMA; PRACTICE GUIDELINE; TUMOR BIOPSY; BONE TUMOR; FRANCE; MEDICAL SOCIETY; ONCOLOGY; REVIEW; STANDARD;

ANTINEOPLASTIC AGENTS; BONE NEOPLASMS; FOLLOW-UP STUDIES; FRANCE; HUMANS; MEDICAL ONCOLOGY; OSTEOSARCOMA; SOCIETIES, MEDICAL;

EID: 0032587393     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (145)

1. Alkins SA, Byrd JC, Morgan SK, Ward FT, Weiss RB. Anaphylactoid reactions to methotrexate. Cancer 1996 ; 77 : 2123-6.
2. Almeida M, Oliveira P, Martins AG, Mendonça E. The role of FNAC in the diagnosis and management of children with bone lesions. Med Pediatr Oncol 1996 ; 27 : 309.
3. Babin SR, Simon P, Babin-Boilletot A, Bellocq JP. Can amputation be avoided in local recurrence after limb salvage for high grade osteosarcoma ? A case report and a review of the literature. Int Orthop 1995 ; 19 : 374-6.
4. Bacci G, Picci P, Ruggieri P, Mercuri M, Avella M, Capanna R, et al. Primary chemotherapy and delayed surgery (neoadjuvant chemotherapy) for osteosarcoma of the extremities. The Istituto Rizzoli experience in 127 patients treated preoperatively with intravenous methotrexate (high versus moderate doses) and intraarterial cisplatin. Cancer 1990 ; 65 : 2539-53.
5. Bacci G, Picci P, Ferrari S, Ruggieri P, Casadei R, Tienghi A, et al. Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin. Cancer 1993 ; 72 : 3227-38.
6. Bacci G, Ruggieri P, Picci P, Briccoli A, Ferraro A, Ferrari S, et al. Changing pattern of relapse in osteosarcoma of the extremities treated with adjuvant and neoadjuvant chemotherapy. J Chemother 1995 ; 7 : 230-9.
7. Bacci G, Briccoli A, Mercuri M, Ferrari S, Bertoni F, Gasbarrini A, et al. Osteosarcoma of the extremities with synchronous lung metastases : longterm results in 44 patients treated with neoadjuvant chemotherapy. J Chemother 1998 ; 10 : 69-76.
8. Bacci G, Ferrari S, Delepine N, Bertoni F, Picci P, Mercuri M, et al. Predictive factors of histologic response to primary chemotherapy in osteosarcoma of the extremity : study of 272 patients preoperatively treated with high-dose methotrexate, doxorubicin, and cisplatin [sec comments]. J Clin Oncol 1998 ; 16 : 658-63.
9. Bacci G, Ferrari S, Donati D, Longhi A, Bertoni F, Di Fiore M, et al. Neoadjuvant chemotherapy for osteosarcoma of the extremity in patients in the fourth and fifth decade of life. Oncology Reports 1998 ; 5 : 1259-63.
10. Bacci G, Ferrrari S, Mercuri M, Bertoni F, Picci P, Manfrini M, et al. Predictive factors for local recurrence in osteosarcoma : 540 patients with extremity tumors followed for minimum 2.5 years after neoadjuvant chemotherapy. Acta Orthopaedica Scandinavica 1998 ; 69 : 230-6.
11. Badhwar R, Agarwal M. Rotationplasty as a limb salvage procedure for malignant bone tumours. International Orthopaedics 1998 ; 22 : 122-5.
12. Baldini N, Scotlandi K, Barbanti-Brodano G, Manara MC, Maurici D, Bacci G, et al. Expression of P-glycoprotein in high-grade osteosarcomas in relation to clinical outcome. N Engl J Med 1995 ; 333 : 1380-5.
13. Baldini N, Feugeas Q, Babin-Boilletot A pour le Groupe d'étude des tumeurs osseuses (GETO). Table ronde sur les facteurs pronostiques des ostéosarcomes : les facteurs biologiques. Rev Chir Ortho Réparatrice Appar Mot 1998 ; 84 : 661-5.
14. Belli L, Scholl S, Livartowski A, Ashby M, Palangie T, Levasseur P, et al. Resection of pulmonary metastases in osteosarcoma. A retrospective analysis of 44 patients. Cancer 1989 ; 63 : 2546-50.
15. Bentzen SM, Poulsen HS, Kaae S, Jensen OM, Johansen H, Mouridsen HT, et al. Prognostic factors in osteosarcomas. A regression analysis. Cancer 1988 ; 62 : 194-202.
16. Bielack SS, Kempf-Bielack B, Winkler K. Osteosarcoma : relationship of response to preoperative chemotherapy and type of surgery to local recurrence. Med Pediatr Oncol 1996 ; 14 : 683-4.
17. Bieling P, Rehan N, Winkler P, Helmke K, Maas R, Fuchs N, et al. Tumor size and prognosis in aggressively treated osteosarcoma. Med Pediatr Oncol 1996 ; 14 : 848-58.
18. Bilbao JI, Martin Algarra S, Martinez de Negri J, Lecumberri F, Longo J, Sierrasesumaga L, et al. Osteosarcoma : correlation between radiological and histological changes after intra-arterial chemotherapy. Eur J Radiol 1990 ; 11 : 98-103.
19. Boriani S, Biagini R, De Iure F, Bandiera S, Di Fiore M, Bandello L, et al. Resection surgery in the treatment of vertebral tumors. Chirurgia Degli Organi di Movimento 1988 ; 83 :53-64.
20. Bramwell VH, Burgers M, Sneath R, Souhami R, van Oosterom AT, Voute PA, et al. A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults : the first study of the European Osteosarcoma Intergroup. J Clin Oncol 1992 ; 10 : 1579-91.
21. Bramwell VH. The role of chemotherapy in osteogenic sarcoma. Crit Rev Oncol Hematol 1995 ; 20 : 61-85.
22. Bruland OS, Fodstad O, Aas M, Solheim OP, Hoie J, Skretting A, et al. Immunoscintigraphy of bone sarcomas-results in 5 patients. Spine 1994 ; 30A : 1484-9.
23. Bruland OS, Pihl A. On the current management of osteosarcoma. A critical evaluation and a proposal for a modified treatment strategy. Eur J Cancer 1997 ; 33 : 1725-31.
24. Caluser CI, Abdel-Dayem HM, Macapinlac HA, Scott A, Healey JH, Huvos A, et al. The value of thallium and three-phase bone scans in the evaluation of bone and soft tissue sarcomas. Eur J Nucl Med 1994 ; 21 : 1198-205.
25. Campanacci M, Cervelatti G. Osteosarcoma. A review of 345 cases. Italian J Orthop Traumatol 1975 ; 1 : 5-22.
26. Canpolat C, Pearson P, Robertson R, Jaffe N. Ifosfamide tolerance in osteosarcoma patients previously treated with cis-diamminedichloroplatinum-II : renal, hematologic, and neurologic observations. Med Pediatr Oncol 1996 ; 26 : 36-47.
27. Carrasco CH, Charnsangavej C, Raymond AK, Richli WR, Wallace S, Chawla SP, et al. Osteosarcoma : angiographic assessment of response to preoperative chemotherapy. Radiology 1989 ; 170 (3 Pt 1) : 839-42.
28. Carrie C, Breteau N, Negrier S, Frappaz D, Bouffet E, Thiesse P, et al. The role of fast neutron therapy in unresectable pelvic osteosarcoma : preliminary report. Med Pediatr Oncol 1994 ; 22 : 355-7.
29. Choong PF, Pritchard DJ, Rock MG, Sim FH, McLeod RA, Unni KK. Low grade central osteogenic sarcoma. A long-term followup of 20 patients. Clin Orthop 1996 ; 322 : 198-206.
30. Chuang VP, Benjamin R, Jaffe N, Wallace S, Ayala AG, Murray J, et al. Radiographic and angiographic changes in osteosarcoma after intraarterial chemotherapy. Am J Roentgenol 1982 ; 139 : 1065-9.
31. Contesso G, Zafrani B, Mazabraud A, Lacombe MJ, Zemoura L, Genin J, et al. Place de l'anatomopathologiste dans le traitement des sarcomes ostéogènes. Rev Chir Orthop 1987 ; 73 : 301-6.
32. Davis AM, Bell RS, Goodwin PJ. Prognostic factors in osteosarcoma : a critical review. J Clin Oncol 1994 ; 12 : 423-31.
33. De Baere T, Vanel D, Shapeero LG, Charpentier A, Terrier P, di Paola M. Osteosarcoma after chemotherapy : evaluation with contrast material-enhanced subtraction MR imaging. Radiology 1992 ; 185 : 587-92.
34. Delepine N, Delepine G, Bacci G, Rosen G, Desbois JC. Influence of methotrexate dose intensity on outcome of patients with high grade osteogenic osteosarcoma. Analysis of the literature [see comments]. Cancer 1996 ; 78 : 2127-35.
35. Den Heeten GJ, Thijn CJ, Kamps WA, Schraffordt Koops H, Oosterhuis JW, Oldhoff J. The effect of chemotherapy on osteosarcoma of the extremities as apparent from conventional roentgenograms. Pediatr Radiol 1986 ; 16 : 407-11.
36. Djerassi I, Cleselka W, Kim J. Removal of methotrexate by filtration absorption using charcoal filters by hemodialysis. Cancer Treat Rep 1977 ; 61 : 751-2.
37. Dreghorn CR, Newman RJ, Hardy GJ, Dickson RA. Primary tumors of the axial skeleton. Experience of the Leeds Regional Bone Tumor Registry. Spine 1990 ; 15 : 137-40.
38. Dubousset J, Missenard G, Kalifa C. Management of osteogenic sarcoma in children and adolescents. Clin Orthop 1991 ; 270 : 52-9.
39. Edeline V, Frouin F, Bazin JP, di Paola M, Kalifa C, Concesso G, et al. Factor analysis as a means of determining response to chemotherapy in patients with osteogenic sarcoma. Eur J Nucl Med 1993 ; 20 : 1175-85.
40. Eilber F, Giuliano A, Eckardt J, Patterson K, Moseley S, Goodnight J. Adjuvant chemotherapy for osteosarcoma : a randomized prospective trial. J Clin Oncol 1987 ; 5 : 21-6.
41. Erlemann R, Sciuk J, Bosse A, Ritter J, Kusnierz-Glaz CR, Peters PE, et al. Response of osteosarcoma and Ewing sarcoma to preoperarive chemotherapy : assessment with dynamic and static MR imaging and skeletal scintigraphy. Radiology 1990 ; 175 : 791-796
42. Eustace S, Suojanen J, Marianacci E, Rahemtulla A, Buff B, Poulin M. Osteosarcoma of the hard palate. Skeletal Radiol 1995 ; 24 : 392-4.
43. Farrugia DC, Rashid AM, Parker MC. Primary osteosarcoma of the breast. Eur J Surg Oncol 1995 ; 21 : 686-8.
44. Fervers B, Bonichon F, Demard F, Heron JF, Mathoulin S, Philip T, et al. Méthodologie de développement des standards, options et recommandations diagnostiques et thérapeutiques en cancérologie. Bull Cancer 1995 ; 82 : 761-7.
45. Feugas O, Guriec N, Babin-Boilletot A, Marcellin N, Simon P, Oberling F. PCR RB gene studies in high grade osteosarcoma : could it be a pronostic factor ? Med Pediatr Oncol 1993 ; 21 : 541.
46. Finn HA, Simon MA. Limb-salvage surgery in the treatment of osteosarcoma in skeletally immature individuals. Clin Orthop 1991 ; 262 : 108-18.
47. Fletcher BD, Hanna SL, Fairclough DL, Gronemeyer SA. Pediatric musculoskeletal tumors : use of dynamic, contrast-enhanced MR imaging to monitor response to chemotherapy. Radiology 1992 ; 184 : 243-8.
48. Fletcher BD. Imaging pediatric bone sarcomas. Diagnosis and treatment-related issues. Radiologic Clinics of North America 1997 ; 35 : 1477-94.
49. Gentet JC, Brunat-Mentigny M, Demaille MC, Pein F, Avet-Loiseau H, Berger C, et al. Ifosfamide and etoposide in childhood osteosarcoma. A phase II study of the French Society of Paediatric Oncology. Eur J Cancer 1997 ; 33 : 232-7.
50. Gillespy T, Manfrini M, Ruggieri P, Spanier SS, Pettersson H, Springfield DS. Staging of intraosseous extent of osteosarcoma : correlation of preoperative CT and MR imaging with pathologic macroslides. Radiology 1988 ; 167 : 765-7.
51. Glasser DB, Lane JM, Huvos AG, Marcove RC, Rosen G. Survival, prognosis, and therapeutic response in osteogenic sarcoma. The Memorial Hospital experience. Cancer 1992 ; 69 : 698-708.
52. Gonzalez-Herranz P, Burgos-Flores J, Ocete-Guzman JG, Lopez-Mondejar JA, Amaya S. The management of limb-length discrepancies in children after treatment of osteosarcoma and Ewing's sarcoma. J Pediatr Orthop 1995 ; 15 : 561-5.
53. Goorin AM, Perez Atayde A, Gebhardt M, Andersen JW, Wilkinson RH, Delorey MJ, et al. Weekly high-dose methotrexate and doxorubicin for osteosarcoma : the Dana-Farber Cancer Institute/the Children's Hospital-study III. J Clin Oncol 1987 ; 5 : 1178-84.
54. Graf N, Winkler K, Betlemovic M, Fuchs N, Bode U. Methotrexate pharmacokinetics and prognosis in osteosarcoma. J Clin Oncol 1994 ; 12 : 1443-51.
55. Graham NJ, Cairns RA, Anderson RA. Osteosarcoma in a 19-month-old girl. Can Assoc Radiol J 1996 ; 47 : 33-5.
56. Green R, Saifuddin A, Cannon S. Pictorial review : imaging of primary osteosarcoma of the spine. Clin Radiol 1996 ; 51 : 325-9.
57. Grem JL, King SA, Wittes RE, Leyland Jones B. The role of methotrexate in osteosarcoma. J Natl Cancer Inst 1988 ; 80 : 626-55.
58. Haines DM, Bruland OS, Matte G, Wilkinson AA, Meric SM, Fowler JD. Immunoscintigraphic detection of primary and metastatic spontaneous canine osteosarcoma with F(ab')2 fragments of osteosarcoma-associated monoclonal antibody TP-1. Anticancer Res 1992 ; 12 : 2151-7.
59. Harris MB, Cantor AB, Goorin AM, Shochat SJ, Ayala AG, Ferguson WS, et al. Treatment of osteosarcoma with ifosfamide : comparison of response in pediatric patients with recurrent disease versus patients previously untreated : a Pediatric Oncology Group study. Med Pediatr Oncol 1995 ; 24 : 87-92.
60. Hazarika P, Nayak DR, Sahota JS, Rao D, Kapadia RD. Osteogenic sarcoma of sphenoid bone : an extended lateral skull base approach. J Laryngol Otol 1995 ; 109 : 1101-4.
61. Herrlin K, Willen H, Wiebe T. Flare phenomenon in osteosarcoma after complete remission. J Nucl Med 1995 ; 36 : 1429-31.
62. Hoh CK, Hawkins RA, Glaspy JA, Dahlbom M, Tse NY, Hoffman EJ, et al. Cancer detection with whole-body PET using 2-[18F]fluoro-2-deoxy-D-glucose. J Comput Assist Tomogr 1993 ; 17 : 582-9.
63. Holscher HC, Bloem JL, Nooy MA, Taminiau AH, Eulderink F, Hermans J. The value of MR imaging in monitoring the effect of chemotherapy on bone sarcomas. Am J Roentgenol 1990 ; 154 : 763-9.
64. Holscher HC, Hermans J, Nooy MA, Taminiau AH, Hogendoorn PC, Bloem JL. Can conventional radiographs be used to monitor the effect of neoadjuvant chemotherapy in patients with osteogenic sarcoma ? Skeletal Radiol 1996 ; 25 : 19-24.
65. Huckstep RL, Sherry E. Replacement of the proximal humerus in primary bone tumours. Aust N Z J Surg 1996 ; 66 : 97-100.
66. Hudson M, Jaffe MR, Jaffe N, Ayala A, Raymond AK, Carrasco H, et al. Pediatric osteosarcoma : therapeutic strategies, results, and prognostic factors derived from a 10-year experience. J Clin Oncol 1990 ; 8 : 1988-97.
67. Huvos AG, Rosen G, Marcove RC. Primary osteogenic sarcoma : pathologic aspects in 20 patients after treatment with chemotherapy en bloc resection and prothetic bone replacement. Arch Pathol Lab Med 1977 ; 101 : 14-8.
68. Jaffe N, Robertson R, Ayala A, Wallace S, Chuang V, Anzai T, et al. Comparison of intra-artcrial cis-diamminedichloroplatinum II with high-dose methotrexate and citrovorum factor rescue in the treatment of primary osteosarcoma. J Clin Oncol 1985 ; 3 : 1101-4.
69. Jaffe N, Smith D, Jaffe MR, Hudson M, Carrasco H, Wallace S, et al. Intraartcrial cisplatin in the management of stage IIB osteosarcoma in the pediatric and adolescent age group. Clin Orthop 1991 ; 270 : 15-21.
70. Jaffe N, Patel SR, Benjamin RS. Chemotherapy in osteosarcoma. Basis for application and antagonism to implementation ; early controversies surrounding its implementation. Hematol Oncol Clin North Am 1995 ; 9 : 825-40.
71. Jaffe N, Jaffe DM. Tumor size and prognosis in aggressively treated osteosarcoma. Med Pediatr Oncol 1996 ; 14 : 2399-400.
72. Kalifa C, Mlika N, Dubousset J, Contesso G, Vanel D, Lumbroso J. Expérience du protocole T10 dans le service de pédiatrie de l'Institut Gustave-Roussy. Bull Cancer 1988 ; 75 : 207-11.
73. Kamen BA, Weitman SD. High-dose methotrexate : is it warranted ? Pediatr Hematol Oncol 1994 ; 11 : 135-7.
74. Kanabar DJ, Healy J, Pringle J, Plowman N. Staging of osteosarcoma on magnetic resonance imaging (MRI) : correlation of MRI with pathological macroslides. Med Pediatr Oncol 1996 ; 27 : 309.
75. Kawai A, Hamada M, Sugihara S, Hashizume H, Nagashima H, Inoue H. Rotationplasty for patients with osteosarcoma around the knee joint. Acta Med Okayama 1995 ; 49 : 221-6.
76. Kinoshita T, Tatezaki S, Matsuzoki O, Inoue M. Ultrasonographic monitoring of the effects of preoperative chemotherapy in osteosarcoma and Ewing's sarcoma. Int Orthop 1995 ; 19 : 312-4.
77. Kohler R, Lorge F, Brunat Mentigny M, Noyer D, Patricot L. Massive bone allografts in children. Int Orthop 1990 ; 14 : 249-53.
78. Korholz D, Wirtz I, Vosberg H, Ruther W, Jurgens H, Gobel U. The role of bone scintigraphy in the follow-up of osteogenic sarcoma. Spine 1996 ; 32A : 461-4.
79. Kostakoglu L, Panicek DM, Divgi CR, Botet J, Healy J, Larson SM, et al. Correlation of the findings of thallium-201 chloride scans with those of other imaging modalities and histology following therapy in patients with bone and soft tissue sarcomas. Eur J Nucl Med 1995 ; 22 : 1232-7.
80. Kumpan W, et al. The angiographic response of osteosarcoma following pre-operative chemotherapy. Skeletal Radiol 1986 ; 15 : 96-102.
81. Lang P, Vahlensieck M, Matthay KK, Johnston JO, Rosenau W, Gooding CA, et al. Monitoring neovascularity as an indicator to response to chemotherapy in osteogenic and Ewing sarcoma using magnetic resonance angiography. Med Pediatr Oncol 1996 ; 26 : 329-33.
82. Leung S, Marshall GM, al Mahr M, Tobias V, Lee DB, Hughes DO. Prognostic significance of chemotherapy dosage characteristics in children with osteogenic sarcoma. Med Pediatr Oncol 1997 ; 28 : 179-82.
83. Lin J, Leung WT, Ho SK, Ho KC, Kumta SM, Metreweli C, et al. Quantitative evaluation of thallium-201 uptake in predicting chemotherapeutic response of osteosarcoma. Eur J Nucl Med 1995 ; 22 : 553-5.
84. Link MP, Goorin AM, Miser AW, Green AA, Pratt CB, Belasco JB, et al. The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. N Engl J Med 1986 ; 314 :1600-6.
85. Lopez-Perez JM, Fojon Polanco S, Arnal Monreal F, Calvo L, Pradas Montilla G, Villalba Martin C, et al. Sarcoma osteogenico cardiaco condiferenciacion condroblastica. An Med Interna 1996 ; 13 : 178-80.
86. Loyzaga JM, Fernandez Machin P, Sala J. Osteogenic sarcoma of the tongue. Case report and review of the literature. Pathol Res Pract 1996 ; 192 : 75-8 ; discussion 79-80.
87. Maas R, Delling G, Winkler K. Dynamic magnetic resonance imaging for prediction of tumour response during pre-operative chemotherapy in osteosarcomas. Med Pediatr Oncol 1996 ; 27 : 243.
88. Makley JT, Krailo M, Ertel IJ, Fryer CJH, Baum ES, Weetman RM, et al. The relationship of various aspects of surgical management to outcome in childhood non metastatic osteosarcoma. A report from the Children Cancer Study Group. J Pediatr Surg 1980 ; 23 : 146-51.
89. Malawer M, Buch R, Reaman C, Priebat D, Potter B, Khurana J, et al. Impact of two cycles of preoperative chemotherapy with intraarterial cisplatin and intravenous doxorubicin on the choice of surgical procedure for high-grade bone sarcomas of the extremities. Clin Orthop 1991 ; 270 : 214-22.
90. Menendez LR, Fideler BM, Mirra J. Thallium-201 scanning for the evaluation of osteosarcoma and soft-tissue sarcoma. A study of the evaluation and predictability of the histological response to chemotherapy. J Bone Joint Surg Am 1993 ; 75 : 526-31.
91. Messen S, Bonkhoff H, Bruch M, Steffens J, Ziegler M. Primary renal osteosarcoma. Case report and review of the literature. Urol Int 1995 ; 55 : 158-61.
92. Meyers PA, Heller G, Healey J, Huvos A, Lane J, Marcove R, et al. Chemotherapy for nonmetastatic osteogenic sarcoma : the Memorial Sloan-Kettering experience. J Clin Oncol 1992 ; 10 : 5-15.
93. Meyers PA, Heller G, Healey JH, Huvos A, Applewhite A, Sun M, et al. Osteogenic sarcoma with clinically detectable metastasis at initial presentation. J Clin Oncol 1993 ; 11 : 449-53.
94. Minic AJ. Periosteal osteosarcoma of the mandible. Int J Oral Maxillofac Surg 1995 ; 24 : 226-8.
95. Nakic M, Cepulic M, Petkovic I, Stepan J. Milic Z, Lenicek J. Fine Needle Aspiration Cytology (FNAC) in diagnosis of osteosarcoma and Ewing sarcoma. Med Pediatr Oncol 1996 ; 27 : 309.
96. Nomori H, Kobayashi R, Morinaga S. Solitary, thin-walled cavitary lung metastasis of osteogenic sarcoma. Scand J Thorac Cardiovasc Surg 1995 ; 29: 95-6.
97. Panizo C, Patino A, Calasanz MJ, Rifon J, Sierrasesumaga L, Rocha E. Emergence of secondary acute leukemia in a patient treated for osteosarcoma : implications of germline TP53 mutations. Med Ped Oncol 1998 ; 30 : 165-9.
98. Panuel M, Poncet M, Martin-Bouyer P, Coatrieux A. Résultats fournis par la tomodensitométrie et l'IRM dans le bilan d'extension des sarcomes osseux. Chirurgie 1994 ; 120 : 199-200.
99. Panuel M. IRM et nécrose cellulaire après chimiothérapie. Chirurgie 1994 ; 120 : 201.
100. Parkin DM, Stiller CA, Nectoux J. International variations in the incidence of childhood bone rumours. Int J Cancer 1993 ; 53 : 371-6.
101. Petrikowski CG, Pharoah MJ, Lee L, Grace MG. Radiographic differentiation of osteogenic sarcoma, osteomyelitis, and fibrous dysplasia of the jaws. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995 ; 80 : 744-50.
102. Podoloff DA. The role of radionuclide scans in sarcoma. Hematol Oncol Clin North Am 1995 ; 9 : 605-26.
103. Pratt CB, Meyer WH, Luo X, Cain AM, Kaste SC, Pappo AS, et al. Second malignant neoplasms occurring in survivors of osteosarcoma. Cancer 1997 ; 80 : 960-5.
104. Provisor AJ, Ettinger LJ, Nachman JB, Krailo MD, Makley JT, Yunis EJ, et al. Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy : a report from the Children's Cancer Group. J Clin Oncol 1997 ; 15 : 76-84.
105. Pui MH, Tan MH, Kuan JH, Pho RW. Haematopoietic marrow hyperplasia simulating transarticular skip metastasis in osteosarcoma. Australas Radiol 1995 ; 39 : 303-5.
106. Putnam JB, Roth JA. Surgical treatment for pulmonary metastases from sarcoma. Hematol Oncol Clin North Am 1995 ; 9 : 869-87.
107. Rademaker J. Osteosarkom der Schadelkalotte. Differentialdiagnostik und klinische Uberlegungen. Aktuelle Radiol 1996 ; 6 : 159-60.
108. Radig K, Hackel C, Herting J, Oda Y, Mittler U, Neumann W, et al. Expression of P-glycoprotein in high grade osteosarcomas with special emphasis on chondroblastic subtype. General & Diagnostic Pathology 1997 ; 142 : 139-45.
109. 18Fluorodeoxyglucose (FDG), correlates with histological response in children with osteosarcoma (OS) and Ewing sarcoma (ES). Med Pediatr Oncol 1996 ; 27 : 244.
110. Raymond AK, Simms W, Ayala AG. Osteosarcoma. Specimen management following primary chemotherapy. Hematol Oncol Clin North Am 1995 ; 9 : 841-67.
111. Reddick WE, Bhargava R, Taylor JS, Meyer WH, Fletcher BD. Dynamic contrast-enhanced MR imaging evaluation of osteosarcoma response to neoadjuvant chemotherapy. J Magn Reson Imaging 1995 ; 5 : 689-94.
112. Remadi S, Doussis-Anagnostopoulu I, Mac Gee W. Primary osteosarcoma of the breast. Pathol Res Pract 1995 ; 191 : 471-4 ; discussion 475-7.
113. Remy Jardin M, Remy J, Giraud F, Marquette CH. Pulmonary nodules : detection with thick-section spiral CT versus conventional CT. Radiology 1993 ; 187 : 513-20.
114. Rimondi E, Ferrari S, Briccoli A, Iantorno D, Forni G, Bacci G. Osteosarcoma non metastatico delle estremita : pattern di ricaduta in funzione del tipo di trattamento e modulazione del follow-up radiologico del torace. Minerva Med 1996 ; 87 : 9-15.
115. Rodriguez Merchan EC, Sanchez Herrera S, Gonzalez Lopez JM. Limb salvage procedures in osteosarcomas around the knee joint. Rev Paul Med 1994 ; 112 : 661-7.
116. Rosen G, Marcove R, Caparros B, Nirenberg A, Kosloff C, Huvos A. Primary osteogenic sarcoma. The rationale for preoperative chemotherapy and delayed surgery. Cancer 1979 ; 43 : 2163-77.
117. Rosen G, Caparros B, Huvos A, Kosloff C, Nirenberg A, Cacavio A, et al. Preoperative chemotherapy for osteogenic sarcoma : selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer 1982 ; 49 : 1221-30.
118. Rosen G, Loren GJ, Brien EW, Ramana L, Waxman A, Lowenbraun S, et al. Serial thallium-201 scintigraphy in osteosarcoma. Correlation with tumor necrosis after preoperative chemotherapy. Clin Orthop 1993 ; 293 : 302-6.
119. Rosenberg ZS, Lev S, Schmahmann S, Steiner GC, Beltran J, Present D. Osteosarcoma : subtle, rare, and misleading plain film features. Am J Roentgenol 1995 ; 165 : 1209-14.
120. Saeter G, Alvegard TA, Elomaa I, Stenwig AE, Holmstrom T, Solheim OP. Treatment of osteosarcoma of the extremities with the T-10 protocol, with emphasis on the effects of preoperative chemotherapy with single-agent high-dose methotrexate : a Scandinavian Sarcoma Group study. J Clin Oncol 1991 ; 9 : 1766-75.
121. Saeter G, Hoie J, Stenwig AE, Johansson AK, Hannisdal E, Solheim OP. Systemic relapse of patients with osteogenic sarcoma, prognostic factors for long term survival. Cancer 1995 ; 75 : 1084-93.
122. Sasaki K, Jaffe N, Jaffe DM. Radiographic prognostic factors for response to chemotherapy in children and adolescents with osteosarcoma. Standardization of tumor size according to lengh of tumor affected bone and host femur. Reg Cancer Treat 1993 ; 1 : 19-25.
123. Scully SP, Temple HT, O'Keefe RJ, Mankin HJ, Gebhardt M. The surgical treatment of patients with osteosarcoma who sustain a pathologic fracture. Clin Orthop 1996 ; 324 : 227-32.
124. Shapeero LG, Henry-Amar M, Vanel D. Response of osteosarcoma and Ewing sarcoma to preoperative chemotherapy : assessment with dynamic and static MR imaging and skeletal scintigraphy. Invest Radiol 1992 ; 27 : 989-91.
125. Shives TC, Dahlin DC, Sim FH, Pritchard DJ, Earle JD, Dreghorn CR, et al. Osteosarcoma of the spine primary tumors of the axial seleton. Experience of the Leeds Regional Bone Tumor Registry. J Bone Joint Surg [Am] 1990 ; 15 : 137-40.
126. Shulkin BL, Mitchell DS, Ungar DR, Prakash D, Dole MG, Castle VP, et al. Neoplasms in a pediatric population : 2-[F-18]-fluoro-2-deoxy-D-glucose PET studies. Radiology 1995 ; 194 : 495-500.
127. Smeele LE, Kostense PJ, van der Waal I, Snow GB. Effect of chemotherapy on survival of craniofacial osteosarcoma : a systematic review of 201 patients. J Clin Oncol 1997 ; 15 : 363-7.
128. Smith MA, Ungerleider RS, Horowitz ME, Simon R. Influence of doxorubicin dose intensity on response and outcome for patients with osteogenic sarcoma and Ewing's sarcoma. J Natl Cancer Inst 1991 ; 83 :1460-70.
129. Spanier SS, Shuster JJ, van der Griend RA. The effect of local extent of the tumor on prognosis in osteosarcoma. J Bone Joint Surg Am 1990 ;72 : 643-53.
130. Springfield D. Thallium-201 scanning for the evaluation of osteosarcoma and soft-tissue sarcoma. J Bone Joint Surg Am 1993 ; 75 : 1880-1.
131. Sundaresan N, Rosen G, Huvos AG, Krol G. Combined treatment of osteosarcoma of the spine. Neurosurgery 1988 ; 23 : 714-9.
132. Tabone MD, Kalifa C, Rodary C, Raquin M, Valteau Couanet D, Lemerle J. Osteosarcoma recurrences in pediatric patients previously treated with intensive chemotherapy. J Clin Oncol 1994 ; 12 : 2614-20.
133. Taccone A, Di Stadio M, Oliveri M, Oddone M, Occhi M. Multifocal synchronous osteosarcoma. Eur J Radiol 1995 ; 20 : 43-5.
134. Thiesse P, Ongolo-Zogo P, Desuzinges C, Terrier A, Bonmartin A, Sau J, et al. Response of osteosarcoma to pre-operative chemotherapy. Accuracy of dynamic-enhanced MRI and skeletal angioscintigraphy. Med Pediatr Oncol 1996 ; 27 : 308.
135. Tse N, Hoh C, Hawkins R, Phelps M, Glaspy J. Positron emission tomography diagnosis of pulmonary metastases in osteogenic sarcoma. Am J Clin Oncol 1994 ; 17 : 22-5.
136. Van der Woude HJ, Bloem JL, Schipper J, Hermans J, van Eck-Smit BL, van Oostayen J, et al. Changes in tumor perfusion induced by chemotherapy in bone sarcomas : color Doppler flow imaging compared with contrast-enhanced MR imaging and three-phase bone scintigraphy. Radiology 1994 ; 191 : 421-31.
137. Van der Woude HJ, Bloem JL, van Meel M, van't Veer ET, Hogendoorn PCW. Monitoring neoadjuvant chemotherapy in patients with high grade bone sarcoma using perfusion-sensitive imaging techniques. Med Pediatr Oncol 1996 ; 27 : 244.
138. Vanel D, Henry Amar M, Lumbroso J, Lemalet E, Couanet D, Piekarski JD, et al. Pulmonary evaluation of patients with osteosarcoma : roles of standard radiography, tomography, CT, scintigraphy, and tomoscintigraphy. Am J Roentgenol 1984 ; 143 : 519-23.
139. Verstraete KL, Dhooge C, Benoit Y, Poffyn B, Smets A, Laureys G, et al. Moniroring the effect of preoperative chemotherapy in bone tumors with dynamic contrast-enhanced magnetic resonance imaging : results of 5-year prospective study. Med Pediatr Oncol 1996 ; 27 : 308.
140. Weingartner K, Gerharz EW, Neumann K, Pfluger KH, Gruber M, Riedmiller H. Primary osteosarcoma of the kidney. Case report and review of literature. Eur Urol 1995 ; 28 : 81-4.
141. West OC, Reinus WR, Wilson AJ. Quantitative analysis of the plain radiographic appearance of central chondrosarcoma of bone. Invest Radiol 1995 ; 30 : 440-7.
142. Winkler K, Beron G, Kotz R, Salzer Kuntschik M, Beck J, Beck W, et al. Neoadjuvant chemotherapy for osteogenic sarcoma : results of a Cooperative German/Austrian study. J Clin Oncol 1984 ; 2 : 617-24.
143. Winkler K, Beron G, Delling G, Heise U, Kabisch H, Purfurst C, et al. Neoadjuvant chemotherapy of osteosarcoma : results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response. J Clin Oncol 1988 ; 6 : 329-37.
144. Winkler K, Bielack S, Delling G, Salzer Kuntschik M, Kotz R, Greenshaw C, et al. Effect of intraarterial versus intravenous cisplatin in addition to systemic doxorubicin, high-dose methotrexate, and ifosfamide on histologic tumor response in osteosarcoma (study COSS-86). Cancer 1990 ; 66 : 1703-10.
145. 13P MRS of human musculoskeletal tumors in response to chemotherapy. Med Pediatr Oncol 1996 ; 27 : 244.